Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B Vaccines in children with cancer

Pediatric Hematology and Oncology

Volumn 24, Issue 8, 2007, Pages 587-594

  Köksal, Yavuz ^a   Varan, Ali ^a   Aydin, G Burca ^a   Sari, Neriman ^a   Yazici, Nalan ^a   Yalcin, Bilgehan ^a   Kutluk, Tezer ^a   Akyuz, Canan ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Accelerated vaccination schedule; Cancer; Chemotherapy; Children; Combined hepatitis A B vaccine; Hepatitis B vaccine

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; SEROCONVERSION; THERAPY EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEOPLASMS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 37349032437     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701703511     Document Type: Article

References (27)

1. Januszkiewicz D, Wysocki J, Nowak J. Hepatitis B and C virus infection in Polish children with malignancies. Eur J Pediatr. 1997;156:454-456.
2. Kebudi R, Ayan I, Y?lmaz G, Akici F, Görgün Ö, Badur S. Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med Pediatr Oncol. 2000;34:102-105.
3. Sevinir B, Meral A, Gunay U, Ozkan T, Ozuysal S, Sinirtas M. Increased risk of chronic hepatitis in children with cancer. Med Pediatr Oncol. 2003;40:104-110.
4. Berberoglu S, Buyukpamukcu M, Sarialioglu F, Akyuz C, Ilhan I. Hepatitis B vaccination in children with cancer. Pediatr Hematol Oncol. 1995;12:171-178.
5. Goyal S, Pai SK, Kelkar R, Advani SH. Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res. 1998;22:193-195.
6. Guptan RC, Thakur V, Safary A, Sarin SK. Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children. Vaccine. 2002;20:2102-2106.
7. Gonzales RP, Jolley C. Infections of the liver. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ, eds. Rudolphs Pediatrics. New York: McGraw Hill; 2002:1495-1501.
8. Kanra G, Tezcan S, Badur S. Turkish National Study Team. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr. 2002;44:204-210.
9. Koksal Y, Yalcin B, Aydin GB, et al. Immunogenicity of hepatitis a vaccine in children with cancer. Pediatr Hematol Oncol. 2006;23:619-624.
10. Zuckerman JN. The place of accelerated schedules for hepatitis A and B vaccinations. Drugs. 2003;63:1779-1784.
11. Akyol H, Sarialioglu F, Buyukpamukcu M, Karadeniz C, Akyuz C, Kutluk T. Hepatitis-B virus infections in pediatric patients receiving anti-cancer chemotherapy. Turk J Cancer. 1990;20:104-108.
12. Kumar A, Misra PK, Rana GS, Mehrotra R. Infection with hepatitis A, B, delta, and human immunodeficiency viruses in children receiving cycled cancer chemotherapy. J Med Virol. 1992;37:83-86.
13. Polychronopoulou-Androulakaki S, Panagiotou JP, Kostaridou S, Kyratzopoulou A, Haidas S. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine. Pediatr Hematol Oncol. 1996;13:425-431.
14. Bosnak M, Dikici B, Bosnak V, Haspolat K. Accelerated hepatitis B vaccination schedules in childhood. Pediatr Int. 2002;44:663-665.
15. Kaya A, Erol S, Tasyaran MA, Aktas O, Y?lmaz S. Early antibody response of 3-weeks hepatitis B vaccination schedule. Türkiye Tip Dergisi. 1997;2:98-101.
16. Marchou B, Excler JL, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Infect Dis. 1995;172:258-260.
17. Nothdurft HD, Dietrich M, Zuckerman JN, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine. 2002;20:1157-1162.
18. Saltoglu N, Inal AS, Tasova Y, Kandemir O. Comparison of the accelerated and classic vaccination schedules against hepatitis B: three-week hepatitis B vaccination schedule provides immediate and protective immunity. Ann Clin Microbiol Antimicrobiol. 2003;2:10.
19. Santagostino E, Mannucci PM, Gringeri A, et al. Accelerated schedule of hepatitis B vaccination in patients with hemophilia. J Med Virol. 1993;41:95-98.
20. Duval B, Gilca V, Boulianne N, Deceuninck G, Rochette L, De Serres G. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Vaccine. 2005;23:4082-4087.
21. Roberton D, Marshall H, Nolan TM, et al. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine. 2005;23:5099-5105.
22. Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S. Immunogenicity of an accelerated vaccination regime with a combined hepatitis A/B vaccine in patients with chronic hepatitis C. Z Gastroenterol. 2003;41:983-990.
23. Ferreira CT, Leite JC, Taniguchi A, Vieira SM, Pereira-Lima J, da Silveira TR. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr. 2004;39:337-340.
24. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71:477-490.
25. Riedemann S, Reinhardt G, Ibarra H, Frosner GG. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in healthy toddlers and children in Chile. Acta Paediatr. 2004;93:412-414.
26. Santagostino E, Gringeri A, Rocino A, Zanetti A, de Biasi R, Mannucci PM. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemost. 1994;72:508-510.
27. Majda-Stanislawska E, Bednarek M, Kuydowicz J. Immunogenicity of inactivated hepatitis A vaccine in children with chronic liver disease. Pediatr Infect Dis J. 2004;23:571-574.